Seven-Tesla Magnetic Resonance Imaging in Wilson Disease Using Quantitative Susceptibility Mapping for Measurement of Copper Accumulation

ObjectivesIn Wilson disease (WD), the copper content of cerebral tissue is increased, particularly in the basal ganglia. This study investigated whether a change in magnetic susceptibility can be detected using quantitative susceptibility mapping of the brain in patients with WD compared with healthy controls. Materials and MethodsEleven patients with WD (6 with the neurological form, 5 with the hepatic form) and 10 age-matched healthy controls who gave informed consent were examined at 7 T in a whole-body scanner (MAGNETOM; Siemens Medical Solutions, Erlangen, Germany) using a 24-channel phased array coil (Nova Medical). For imaging, a 3-dimensional spoiled gradient multiecho sequence (repetition time, 40 milliseconds; echo time, 9.76/19.19/28.62 milliseconds; bandwidth, 150 hertz per pixel; voxel size, 0.6 × 0.6 × 0.8 mm) was used. The susceptibility of selected regions (substantia nigra, red nucleus, pallidum, putamen, caudate nucleus) was analyzed in susceptibility maps. ResultsThe patients with WD showed significantly increased susceptibility (P value, 0.001–0.05) in all analyzed regions compared with healthy controls. This was evident not only in patients with a neurological syndrome but also, with lower values, in patients with isolated hepatic manifestations. The distribution patterns of copper accumulation were different between the patients with neurological and non–neurological manifestations of the disease. ConclusionsIn neurologically symptomatic and asymptomatic patients with WD, we found increased magnetic susceptibility in the brain tissue using quantitative susceptibility mapping.

[1]  J. Wardlaw,et al.  Identification of mineral deposits in the brain on radiological images: a systematic review , 2012, European Radiology.

[2]  G. Arunodaya,et al.  Wilson’s disease: cranial MRI observations and clinical correlation , 2006, Neuroradiology.

[3]  Xu Li,et al.  Mapping magnetic susceptibility anisotropies of white matter in vivo in the human brain at 7T , 2012, NeuroImage.

[4]  S. Hoffmann,et al.  Analysis of heavy metals content in the brain with the use of electron paramagnetic resonance in a clinically unusual case of hepato-lenticular degeneration. , 1993, Neuropatologia polska.

[5]  Jeff H. Duyn,et al.  High-field MRI of brain cortical substructure based on signal phase , 2007, Proceedings of the National Academy of Sciences.

[6]  M. Fukunaga,et al.  Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure , 2010, Proceedings of the National Academy of Sciences.

[7]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[8]  Ferdinand Schweser,et al.  Toward online reconstruction of quantitative susceptibility maps: Superfast dipole inversion , 2013, Magnetic resonance in medicine.

[9]  M. Cronin,et al.  Metals, toxicity and oxidative stress. , 2005, Current medicinal chemistry.

[10]  Ferdinand Schweser,et al.  Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain , 2012, NeuroImage.

[11]  Ferdinand Schweser,et al.  Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? , 2011, NeuroImage.

[12]  J. Gitlin,et al.  Copper and iron disorders of the brain. , 2007, Annual review of neuroscience.

[13]  W. M. Haynes.  CRC Handbook of Chemistry and Physics , 1990 .

[14]  G. Jansen,et al.  Cranial MR in Wilson disease: abnormal white matter in extrapyramidal and pyramidal tracts. , 1995, AJNR. American journal of neuroradiology.

[15]  E. Haacke,et al.  Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.

[16]  Hidenao Fukuyama,et al.  Microbleeds in Moyamoya Disease: Susceptibility-Weighted Imaging Versus T2*-Weighted Imaging at 3 Tesla , 2008, Investigative radiology.

[17]  M. Schilsky.  Wilson Disease: Genetic Basis of Copper Toxicity and Natural History , 1996, Seminars in liver disease.

[18]  Sheng-gang Sun 孙圣刚,et al.  Determination of brain iron content in patients with Parkinson’s disease using magnetic susceptibility imaging , 2009, Neuroscience Bulletin.

[19]  The effect of gender on brain MRI pathology in Wilson’s disease , 2013, Metabolic Brain Disease.

[20]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[21]  R. Bowtell,et al.  Fiber orientation-dependent white matter contrast in gradient echo MRI , 2012, Proceedings of the National Academy of Sciences.

[22]  I. Wilkinson,et al.  Cranial MR imaging in Wilson's disease. , 1996, AJR. American journal of roentgenology.

[23]  Andreas Schäfer,et al.  Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI , 2009, NeuroImage.

[24]  J. Cumings.  The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. , 1948, Brain : a journal of neurology.

[25]  Chandrasekharan Kesavadas,et al.  Utility of susceptibility-weighted MRI in differentiating Parkinson’s disease and atypical parkinsonism , 2010, Neuroradiology.

[26]  Robert Turner,et al.  Toward in vivo histology: A comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2 ⁎-imaging at ultra-high magnetic field strength , 2013, NeuroImage.

[27]  J R Reichenbach,et al.  Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. , 1997, Radiology.

[28]  R. Bowtell,et al.  Susceptibility mapping in the human brain using threshold‐based k‐space division , 2010, Magnetic resonance in medicine.

[29]  M. Cho,et al.  Widespread cerebral cortical mineralization in Wilson's disease detected by susceptibility-weighted imaging , 2012, Journal of the Neurological Sciences.

[30]  Tobias Kober,et al.  MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field , 2010, NeuroImage.

[31]  A G Webb,et al.  High-field imaging of neurodegenerative diseases. , 2012, Neuroimaging clinics of North America.

[32]  Yu-Chung N. Cheng,et al.  Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.

[33]  J. Reichenbach,et al.  Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. , 2010, Medical physics.

[34]  Z. Wu,et al.  Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2 , 2008, American Journal of Neuroradiology.

[35]  Ferdinand Schweser,et al.  Quantitative Susceptibility Mapping Differentiates between Blood Depositions and Calcifications in Patients with Glioblastoma , 2013, PloS one.

[36]  E. Haacke,et al.  Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1 , 2008, American Journal of Neuroradiology.

[37]  J. Rommens,et al.  The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene , 1993, Nature Genetics.

[38]  H. Nazer,et al.  Wilson's Disease. , 1991, Annals of Saudi medicine.

[39]  Ferdinand Schweser,et al.  Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study , 2012, NeuroImage.

[40]  I. Saatci,et al.  Cranial MR findings in Wilson's disease , 1997, Acta radiologica.

[41]  J. Brismar,et al.  Magnetic resonance imaging of the brain in Wilson's disease , 2004, Neuroradiology.

[42]  Andreas Schäfer,et al.  High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease , 2012, Journal of magnetic resonance imaging : JMRI.

[43]  G. Arunodaya,et al.  Sequential MRI changes in Wilson's disease with de-coppering therapy: a study of 50 patients. , 2007, The British journal of radiology.